Nu-Med Plus (NUMD) Return on Invested Capital (2016 - 2019)
Nu-Med Plus recorded quarterly Return on Invested Capital of 0.04% in Q3 2019, down 34.08% quarter-over-quarter from 0.06% in Q2 2019.
Nu-Med Plus' Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.04% for Q3 2019.
- In Q3 2019, Return on Invested Capital changed N/A year-over-year to 0.04%; the TTM figure through Sep 2019 stood at 0.04% (changed N/A YoY), while the FY2018 annual figure was 0.17%, changed N/A from the prior year.
- Return on Invested Capital came in at 0.04% for Q3 2019 at Nu-Med Plus, down from 0.06% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.18% in Q1 2019 to a low of 0.37% in Q3 2017.
- A 4-year average of 0.02% and a median of 0.0% in 2016 frame the typical range for Return on Invested Capital.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.00% |
| 10 | Nu-Med Plus | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 0.04% |
| Jun 30, 2019 | 0.06% |
| Mar 31, 2019 | 0.18% |
| Dec 31, 2018 | -0.09% |
| Sep 30, 2017 | -0.37% |
| Jun 30, 2017 | -0.01% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |